Serafina Mammoliti

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Corrigendum to "Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancer": [ESMO Gastrointestinal Oncology, Volume 5, 100069].

Corrigendum to "Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancer": [ESMO Gastrointestinal Oncology, Volume 5, 100069].

Journal: ESMO gastrointestinal oncology

Published: April 17, 2026

Membrane IL-18 identifies a human macrophage subset with distinct proteomic and functional traits.

Membrane IL-18 identifies a human macrophage subset with distinct proteomic and functional traits.

Journal: Oncoimmunology

Published: November 06, 2025

PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric survey.

PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric survey.

Journal: ESMO open

Published: August 20, 2025

Immune checkpoint inhibitors in gynecological cancers: a narrative review on the practice-changing trials.

Immune checkpoint inhibitors in gynecological cancers: a narrative review on the practice-changing trials.

Journal: Immunotherapy

Published: February 02, 2025

The role of the Androgen Receptor (AR) in endometrial cancer aggressiveness: Correlation with other prognostic markers and therapeutic implications. A retrospective observational study.

The role of the Androgen Receptor (AR) in endometrial cancer aggressiveness: Correlation with other prognostic markers and therapeutic implications. A retrospective observational study.

Journal: Pathology, research and practice

Published: January 02, 2025

A Comprehensive Approach to Neoadjuvant Treatment of Locally Advanced Rectal Cancer.

A Comprehensive Approach to Neoadjuvant Treatment of Locally Advanced Rectal Cancer.

Journal: Cancers

Published: December 10, 2024

Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancer.

Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancer.

Journal: ESMO gastrointestinal oncology

Published: June 14, 2024

Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study.

Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 13, 2024

Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial.

Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 05, 2024

Corrigendum: Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors.

Corrigendum: Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors.

Journal: Frontiers in oncology

Published: December 18, 2023

The Advantages of Next-Generation Sequencing Molecular Classification in Endometrial Cancer Diagnosis.

The Advantages of Next-Generation Sequencing Molecular Classification in Endometrial Cancer Diagnosis.

Journal: Journal of clinical medicine

Published: July 27, 2023

The prognostic value of FIGO staging defined by combining MRI and [18F]FDG PET/CT in patients with locally advanced cervical cancer.

The prognostic value of FIGO staging defined by combining MRI and [18F]FDG PET/CT in patients with locally advanced cervical cancer.

Journal: Current problems in cancer

Published: July 20, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026